Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer. The company has engaged in deep analyses of tumor antigen-specific tumor-infiltrating lymphocytes (TILs) within hot tumors and of tumor cell signaling pathways within cold tumors, providing laboratories with development of novel antibody-based immunotherapies. It was founded in 2019 and is based in Boston, Massachusetts.

Cambridge, MA, USA

Boston, MA, USA

Pyxis Oncology

Alix Ventures

BIOS Community

Leverage our network to build your career.

#### Welcome!

Thank you for joining Bios Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Bios network as they come up.

You can always update this information later.

Welcome to the Bios talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Bios company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Join TechBio Companies Driving Patient Impact